Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.22.2.2
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Concentration Risk [Line Items]        
Revenues $ 105,389 $ 93,105 $ 289,150 $ 281,600
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 90,311 71,271 208,690 222,223
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 15,078 $ 21,834 $ 80,460 $ 59,377